stockrowAkebia Therapeutics, Inc. (AKBA) vs Anika Therapeutics Inc. (ANIK)
- Akebia Therapeutics, Inc. AKBA 0.43 −37.68%
- Anika Therapeutics Inc. ANIK 19.31 −5.34%
Akebia Therapeutics, Inc. and Anika Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $258.7M against $117.9M — 2.2× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −12.4%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −22.6%) and the lower return on invested capital (−3.24% vs 0.00%). Across the 19 metrics below, Anika Therapeutics Inc. leads on 10 and Akebia Therapeutics, Inc. on 9.
Valuation
Profitability
| Metric | AKBA | ANIK | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 78.90% | 62.16% | 53.51% |
| Operating margin | (15.74%) | (4.24%) | 0.00% |
| Net margin | (22.60%) | (3.14%) | (2.45%) |
| Free cash flow margin | 7.03% | 0.47% | 0.00% |
| Return on equity | (143.83%) | (2.66%) | (0.80%) |
| Return on assets | (12.62%) | (2.04%) | (1.67%) |
| Return on invested capital | 0.00% | (3.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack